Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after μ-opioid receptor blockade in opioid- addicted patients during barbiturate-induced anesthesia for acute detoxification

Anesthesiology

Volumn 88, Issue 5, 1998, Pages 1154-1161

  Kienbaum, Peter ^a   Thürauf, Norbert ^b   Michel, Martin C ^b   Scherbaum, Norbert ^b   Gastpar, Markus ^b   Peters, Jürgen ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b NONE

Author keywords

Opioid receptor blockade; Acute opioid detoxification; Cardiovascular stimulation; Catecholamine plasma concentration; Opioid addiction

Indexed keywords

ADRENALIN; BARBITURIC ACID DERIVATIVE; CEFAZOLIN; FAMOTIDINE; FLUNITRAZEPAM; HEPARIN; METHOHEXITAL; MIDAZOLAM; MIDAZOLAM MALEATE; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE;

ADRENALIN BLOOD LEVEL; ADRENALIN RELEASE; ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; FEMALE; GENERAL ANESTHESIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NARCOTIC DEPENDENCE; PRIORITY JOURNAL; RECEPTOR BLOCKING; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPINEPHRINE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHOHEXITAL; NALOXONE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID, MU;

EID: 0344157334     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199805000-00004     Document Type: Article

References (35)

1. Mattick RP: Are detoxification programs effective? Lancet 1996; 347:97-100
2. Loimer N, Schmid RW, Presslich O, Lenz K: Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatr Res 1989; 23:81-6
3. Loimer N, Schmidt R, Lenz K, Presslich O, Grünberger J: Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. Br J Psychiatry 1990; 157:748-52
4. Loimer N, Hofmann P, Chaudhry H: Ultrashort noninvasive opiate detoxification. Am J Psychiatry 1993; 150:839
5. Gossop M, Griffiths P, Bradley B, Strang J: Opiate withdrawal responses to 10-day and 21-day methadone withdrawal programs. Br J Psychiatry 1991; 148:1291-300
6. Legarda JJ, Gossop M: A 24-h inpatient detoxification treatment for heroin addicts: A preliminary investigation. Drug Alcohol Depend 1994; 35:91-3
7. Ganz W, Swan HJC: Measurement of blood flow by thermodilution. Am J Cardiol 1972; 29:241-6
8. Jansen JRC, Schreuder JJ, Settels JJ, Kloek JJ, Versprille AA: An adequate strategy for the thermodilution technique during mechanical ventilation. Intensive Care Med 1990; 16:422-5
9. Bauch HJ, Kelsch U, Hauss WH: Einfache, schnelle, selektive und quantitative Bestimmung von Adrenalin und Noradrenalin im Plasma durch Kombination von Flüssigkeitsextraktion, HPLC-Trennung und elektrochemischer Detektion. J Clin Chem Clin Biochem 1986; 24:651-8
10. Victor RG, Leimbach WN Jr: Effects of lower body negative pressure on sympathetic discharge to leg muscles in humans. J Appl Physiol 1987; 63:2558-62
11. Somers VK, Mark AL, Zavala DC, Abboud FM: Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989; 67:2101-6
12. Macefield VG, Wallin BG: Modulation of muscle sympathetic activity during spontaneous and artificial ventilation and apnoea in humans. J Autonom Nerv Syst 1995; 53:137-47
13. Sellgren J, Ponten J, Wallin BG: Characteristics of muscle sympathetic activity during general anaesthesia in humans. Acta Anaesthesiol Scand 1992; 36:336-45
14. Ebert TJ, Kanitz DD, Kampine JP: Inhibition of sympathetic neural outflow during thiopental anesthesia in humans. Anesth Analg 1990; 71:319-26
15. Peiss CN, Manning JW: Effects of sodium pentobarbital on electrical and reflex activation of the cardiovascular system. Circ Res 1964; 14:228-35
16. Inoue K, Amdt JO: Efferent vagal discharge and heart rate in response to methohexitone, althesin, ketamine and etomidate in cats. Br J Anaesth 1982; 54:1105-16
17. Tanaka GY: Hypertensive reaction to naloxone. JAMA 1974; 228:25-6
18. Flacke JW, Flacke WE, Williams GD: Acute pulmonary edema following reversal of high-dose morphine anesthesia. ANESTHESIOLOGY 1977; 47:376-8
19. Andree RA: Sudden death following naloxone administration. Anesth Analg 1980; 59:782-4
20. Taff RH: Pulmonary edema following low-dose naloxone administration. ANESTHESIOLOGY 1983; 59:576-7
21. Partridge BL, Ward CF: Pulmonary edema following low-dose naloxone administration. ANESTHESIOLOGY 1986; 65:709-10
22. Johnson C, Mayer P, Grosz D: Pulmonary edema following naloxone administration in a healthy orthopedic patient. J Clin Anesth 1995; 7:356-7
23. Pfab T, Hirtl C, Hibler A, Felgenheuer N, Chlistalla J, Zilker TH: Der Antagonist-induzierte, Narkose-gestützte Opiat-Schnellentzug (AINOS). Münch Med Wochenschr 1996; 138:781-6
24. Resnick RB, Kestenbaum RS, Washton A, Poole D: Naloxone-precipitated withdrawal: A method for rapid induction onto naltrexone. Clin Pharmacol Ther 1977; 21:409-13
25. Dettling M, Tretter F: Der Opiatentzug in Narkose (forcierter Narkosentzug, "Turboentzug") bei Opiatabhängigkeit. Nervenarzt 1996; 67:805-10
26. Estilo AE, Cottrell JE: Hemodynamic and catecholamine changes after administration of naloxone. Anesth Analg 1982; 61:349-53
27. Mannelli M, Maggi M, De Feo ML, Cuomo S, Delitala G, Giusti G, Serio M: Effects of naloxone on catecholamine plasma levels in adult men: A dose-response study. Acta Endocrinologica 1984; 106:357-61
28. Bouloux PM, Grossman A, Al-Damluji S, Bailey T, Besser M: Enhancement of the sympathoadrenal response to the cold-pressure test by naloxone in man. Clin Sci 1985; 69:365-8
29. Farrell PA, Ebert TJ, Kampine JP: Naloxone augments muscle sympathetic nerve activity during isometric exercise in humans. Am J Physiol 1991; 260:E379-88
30. Schobel HP, Oren RM, Mark AAL, Ferguson DW: Naloxone potentiates cardiopulmonary baroreflex sympathetic control in normal humans. Circ Res 1992; 70:172-83
31. Delle M, Ricksten SE, Haggendal J, Olsson K, Skarphedinson JO, Thorén P: Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catechol-amines, renin and vasopressin during naloxone-precipitated morphine withdrawal in rats. J Pharmacol Exp Ther 1990; 253:646-54
32. Chang APL, Dioxon WR: Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats. J Pharmacol Exp Ther 1990; 254:857-63
33. Stratton JR, Pfeifer MA, Ritcher JL, Halter JB: Hemodynamic effects of epinephrine: Concentration-effect study in humans. J Appl Physiol 1985; 58:1199-206
34. Kimura T, Katoh M, Satoh S: Inhibition by opioid agonists and enhancement by antagonists of the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: Evidence for the functional role of opioid receptors. J Pharmacol Exp Ther 1988; 244:1098-102
35. Schobel HP, Oren RM, Mark AAL, Ferguson DW: Naloxone potentiates cardiopulmonary baroreflex sympathetic control in normal humans. Circ Res 1992; 70:172-83